ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000226067.2	ABT-263 (navitoclax)	Lymphoid neoplasm diffuse large B-cell lymphoma	0.041284561	Resistant
ENSG00000226067.2	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.002019684	Resistant